A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma.

Authors

Robert A. Ramirez, LSU Health Sciences Center - New OrleansFollow
Marc Ryan Matrana, Ochsner
Suma Satti, Ochsner
Ryan Patrick Griffin, Ochsner
Brianne A. Voros, LSU Health Sciences Center - New OrleansFollow
Yvette Bren-Mattison, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

2-4-2020

Publication Title

Journal of clinical oncology

Volume

38(4 Suppl)

Recommended Citation

Ramirez, Robert A.; Matrana, Marc Ryan; Satti, Suma; Griffin, Ryan Patrick; Voros, Brianne A.; and Bren-Mattison, Yvette, "A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma." (2020). School of Medicine Faculty Publications. 1789.
https://digitalscholar.lsuhsc.edu/som_facpubs/1789